Mission
Overview
Primary Target
Technology
Clinical
Market
Team
For Investors
Intellectual Property
Publications
News
Contact
Copyright © 2013-2017
ILiAD Biotechnologies
All rights reserved.
Technology
Technical Profile
Safety Profile
Phase I Human Study
“BPZE1 is safe in healthy adults and able to transiently colonize the nasopharynx. It induces immune responses in all colonized individuals.”
– Conclusion of Phase 1 human clinical study
Thorstensson et. al., PLOS, Jan. 8, 2014